Exogenous GM1 gangliosides induce partial recovery of the nigrostriatal dopaminergic system in MPTP-treated young mice but not in aging mice
Open Access
- 1 December 1989
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 106 (3), 282-286
- https://doi.org/10.1016/0304-3940(89)90177-8
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- VII. The biotransformation of MPTP and disposition of MPP+: Tge effects of agingLife Sciences, 1987
- Administration of GMI. ganglioside restores the dopamine content in striatum after chronic treatment with MPTPNeuropharmacology, 1986
- Age-dependent effects of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP)Neuropharmacology, 1985
- Effect of GM1 ganglioside on neonatally neurotoxin induced degeneration of serotonin neurons in the rat brainDevelopmental Brain Research, 1984
- Effect of GM1 ganglioside treatment on the recovery of dopaminergic nigro‐striatal neurons after different types of lesionActa Physiologica Scandinavica, 1984
- Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonismNature, 1984
- Dopaminergic Neurotoxicity of 1-Methyl-4-Phenyl-1,2,5,6-Tetrahydropyridine in MiceScience, 1984
- Gangliosides minimize behavioral deficits and enhance structural repair after brain injuryJournal of Neuroscience Research, 1984
- Biology of gangliosides: Neuritogenic and neuronotrophic propertiesJournal of Neuroscience Research, 1984
- Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.Journal of Histochemistry & Cytochemistry, 1981